These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 893790)

  • 1. Technetium-99m stannous citrate brain-tumor uptake in mice: concise communication.
    Haynie TP; Konikowski T; Glenn HJ
    J Nucl Med; 1977 Sep; 18(9):915-8. PubMed ID: 893790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal clearance and brain tumor localization in mice of 99 m Tc compounds of (Sn), DTPA, (iron-ascorbic acid) DTPA, and iron-ascorbic acid.
    Konikowski T; Glenn HJ; Haynie TP
    J Nucl Med; 1972 Nov; 13(11):834-42. PubMed ID: 5080017
    [No Abstract]   [Full Text] [Related]  

  • 3. Brain tumor-scanning agents compared in an animal model.
    Konikowski T; JPAHNS MF; Haynie P; Glenn HJ
    J Nucl Med; 1975 Mar; 16(3):200-7. PubMed ID: 46273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m labeled agents for skeletal imaging.
    Thrall JH
    CRC Crit Rev Clin Radiol Nucl Med; 1976; 8(1):1-31. PubMed ID: 789010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shortcomings of 99m Tc-pertechnetate as a tracer for brain tumor detection as shown by well counting of human brain tumors and a mouse ependymoblastoma.
    Schwartz ML; Tator CH
    J Nucl Med; 1972 May; 13(5):321-7. PubMed ID: 4336247
    [No Abstract]   [Full Text] [Related]  

  • 6. Kinetics of 111In-bleomycin and 111 In-chlorides in mice.
    Konikowski T; Haynie TP; Glenn HJ
    J Nucl Med; 1975 Aug; 16(8):738-43. PubMed ID: 51922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor imaging after administration of 99mTc-labeled bleomycin.
    Mori T; Hamamoto K; Onoyama Y; Torizuka K
    J Nucl Med; 1975 May; 16(5):414-22. PubMed ID: 53278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.
    van Schaijk FG; Oosterwijk E; Soede AC; Oyen WJ; McBride WJ; Griffiths GL; Goldenberg DM; Corstens FH; Boerman OC
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3880S-5S. PubMed ID: 14506186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of the Tc 99m-Sn complex in brain scanning].
    Kuba J; Charamza OC; Klaus E; Sevcik M
    Radiobiol Radiother (Berl); 1971; 12(4):501-6. PubMed ID: 5140055
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukocyte labeling with technetium-99m tin colloids.
    Mock BH; English D
    J Nucl Med; 1987 Sep; 28(9):1471-7. PubMed ID: 3625299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m-glucoheptonate as a brain-scanning agent: critical comparison with pertechnetate.
    Waxman AD; Tanacescu D; Siemsen JK; Wolfstein RS
    J Nucl Med; 1976 May; 17(5):345-8. PubMed ID: 1262934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits.
    Kowalsky RJ; Dalton DR
    Am J Hosp Pharm; 1981 Nov; 38(11):1722-6. PubMed ID: 7304626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of the Tc 99m -Sn-complex in brain scintigraphy].
    Kuba J; Charamza O; Klaus E; Sevcík M
    Radiol Diagn (Berl); 1971; 12(4):501-6. PubMed ID: 5147685
    [No Abstract]   [Full Text] [Related]  

  • 14. Technetium-99m-labeled stannous imidodiphosphate, a new radiodiagnostic agent for bone scanning: comparison with other 99mTc complexes.
    Subramanian G; McAfee JG; Blair RJ; Rosenstreich M; Coco M; Duxbury CE
    J Nucl Med; 1975 Dec; 16(12):1137-43. PubMed ID: 1194964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ distribution of 99m-Tc-and 51-Cr-labelled thymocytes.
    Barth RF; Singla O
    J Nucl Med; 1975 Jul; 16(7):633-8. PubMed ID: 1151482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radionuclide scanning in the evaluation of Kaposi sarcoma.
    Krishnamurthy GT; Singhi V; Taylor RD; Ranganath K; Blahd WH
    Arch Intern Med; 1976 Apr; 136(4):400-3. PubMed ID: 944558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of formamidine sulfinic acid and other reducing agents for use in the preparation of Tc-99m labeled radiopharmaceuticals.
    Fritzberg AR; Lyster DM; Dolphin DH
    J Nucl Med; 1977 Jun; 18(6):553-7. PubMed ID: 192859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
    Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
    J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kinetics of 99m Tc-, 113m In-, and 169 Yb-DTPA compounds in brain sarcoma and kidneys of mice.
    Haynie TP; Konikowski T; Glenn HJ
    J Nucl Med; 1972 Mar; 13(3):205-10. PubMed ID: 5058238
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of perchlorate on the localization of 99mTc-pertechnetate in a mouse brain sarcoma.
    Konikowski T; Haynie TP
    J Nucl Med; 1970 Jul; 11(7):443-8. PubMed ID: 4317181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.